Wegovy generally leads to more significant weight loss than Contrave, according to the results of separate studies
The Food and Drug Administration (FDA) has approved both drugs for weight management in adults with: a body mass index (BMI) of 30 or higher (obesity) a BMI of 27 or higher (overweight) plus at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol Wegovy also has the following approved uses: Cardiovascular health: Wegovy is approved to reduce the risk of major heart-related events like heart attack or stroke in adults with known heart disease who have obesity or are overweight
Acute pancreatitis usually comes on quickly, and typically lasts only a handful of days
Avoid platforms that issue prescriptions after questionnaire-only review with no physician interaction
In practice, pills may work well for: Patients are afraid of needles Frequent travelers Patients want easier storage Those preferring daily routines Shots may work better for: Patients who forget their daily medication Those wanting weekly dosing convenience Patients needing a maximal weight loss response Common Side Effects of GLP-1 Medications Most side effects affect the digestive system
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have become common therapies in the management of chronic conditions such as diabetes and obesity
